Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-urgn
/
Urogen Pharma Ltd
URGN
Add to Watchlist
37.940
USD
+1.140
+3.10%
Close 07/01, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/02, 09:30 (ET)
1.85B
Market Cap
Loss
P/E TTM
Urogen Pharma Ltd
37.940
+1.140
+3.10%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Thu, Feb 19
Updated: Thu, Feb 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RTW Investments L.P.
9.33%
Paradigm BioCapital Advisors LP
9.18%
Morgan Stanley & Co. LLC
5.12%
Jefferies LLC
4.51%
BlackRock Institutional Trust Company, N.A.
4.50%
Other
67.35%
Shareholders
Shareholders
Proportion
RTW Investments L.P.
9.33%
Paradigm BioCapital Advisors LP
9.18%
Morgan Stanley & Co. LLC
5.12%
Jefferies LLC
4.51%
BlackRock Institutional Trust Company, N.A.
4.50%
Other
67.35%
Shareholder Types
Shareholders
Proportion
Investment Advisor
25.15%
Hedge Fund
24.30%
Investment Advisor/Hedge Fund
21.45%
Research Firm
14.56%
Insurance Company
3.98%
Pension Fund
2.38%
Individual Investor
1.94%
Private Equity
1.80%
Corporation
1.72%
Other
2.73%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
349
46.29M
95.00%
-15.69M
2025Q4
321
48.31M
103.21%
-13.86M
2025Q3
311
45.66M
97.55%
-6.58M
2025Q2
285
53.00M
114.72%
+5.27M
2025Q1
290
49.25M
108.64%
+1.67M
2024Q4
280
43.94M
103.24%
-1.94M
2024Q3
262
44.13M
104.63%
-2.19M
2024Q2
247
46.02M
111.40%
+11.07M
2024Q1
255
34.96M
99.86%
+5.57M
2023Q4
237
29.16M
94.80%
+4.33M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RTW Investments L.P.
4.54M
9.71%
--
--
Sep 30, 2025
Paradigm BioCapital Advisors LP
4.22M
9.01%
+1.88M
+80.79%
Sep 30, 2025
Morgan Stanley & Co. LLC
2.46M
5.25%
+983.01K
+66.65%
Sep 30, 2025
Jefferies LLC
2.20M
4.7%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.14M
4.58%
+33.75K
+1.60%
Sep 30, 2025
SilverArc Capital Management, LLC
1.58M
3.37%
-445.20K
-22.01%
Sep 30, 2025
SG Americas Securities, L.L.C.
1.16M
2.47%
+8.30K
+0.72%
Sep 30, 2025
Acorn Capital Advisors, LLC
1.26M
2.69%
--
--
Sep 30, 2025
American Century Investment Management, Inc.
1.36M
2.79%
+1.36M
+189678.21%
Dec 31, 2025
UBS Asset Management Switzerland AG
1.32M
2.82%
--
--
Jan 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ARK Israel Innovative Technology ETF
2.09%
Tema Oncology ETF
1.92%
ALPS Medical Breakthroughs ETF
0.39%
Hypatia Women CEO ETF
0.28%
ProShares Ultra Nasdaq Biotechnology
0.16%
iShares Micro-Cap ETF
0.15%
Fidelity Enhanced Small Cap ETF
0.11%
Vanguard US Momentum Factor ETF
0.1%
Invesco Nasdaq Biotechnology ETF
0.09%
iShares Biotechnology ETF
0.07%
View more
ARK Israel Innovative Technology ETF
Proportion
2.09%
Tema Oncology ETF
Proportion
1.92%
ALPS Medical Breakthroughs ETF
Proportion
0.39%
Hypatia Women CEO ETF
Proportion
0.28%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.16%
iShares Micro-Cap ETF
Proportion
0.15%
Fidelity Enhanced Small Cap ETF
Proportion
0.11%
Vanguard US Momentum Factor ETF
Proportion
0.1%
Invesco Nasdaq Biotechnology ETF
Proportion
0.09%
iShares Biotechnology ETF
Proportion
0.07%